Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

BACKGROUND: Hepatic artery infusion chemotherapy (HAIC) and anti-programmed cell death protein-1 (PD-1) immunotherapy have shown promising outcomes in patients with advanced hepatocellular carcinoma (HCC), respectively. However, the combination of the two treatments has not been reported. In this st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Hepatocell Carcinoma
Auteurs principaux: Mei, Jie, Li, Shao-Hua, Li, Qi-Jiong, Sun, Xu-Qi, Lu, Liang-He, Lin, Wen-Ping, Zheng, Lie, Chen, Min-Shan, Shi, Ming, Wei, Wei, Guo, Rong-Ping
Format: Artigo
Langue:Inglês
Publié: Dove 2021
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007560/
https://ncbi.nlm.nih.gov/pubmed/33791252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S298538
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires